TRACON Pharmaceuticals, Inc. Gains 18.49%

Thu 10 Sep 20 at 05:30 PM
TRACON Pharmaceuticals, Inc. Gains 18.49%

TRACON Pharmaceuticals, Inc. (TCON:NASDAQ) shot up at $4.23, a gain of 18.5%. On Wed 09 Sep 20, TCON:NASDAQ hit a New 2-Week Intraday High of $4.05. The stock appeared on our News Catalysts scanner on Thu 10 Sep 20 at 08:46 AM in the 'MISCELLANEOUS' category. From Wed 26 Aug 20, the stock recorded 88.89% Up Days and 80.00% Green Days

About TRACON Pharmaceuticals, Inc. (TCON:NASDAQ)

TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.

Share